Literature DB >> 4451761

The cardiovascular effects of L-dopa in the pithed rat.

E Eden, P A Nasmyth.   

Abstract

1 L-DOPA (1-2 mg i.v.) in the pithed rat reduced the arterial and increased the venous pressure responses to noradrenaline.2 Infusions of dopamine (4-8 mug kg(-1) min(-1)) and noradrenaline (500 ng kg(-1) min(-1)) also reduced the pressor responses to noradrenaline. The pressor response did not recover after stopping dopamine infusions, but it usually did so after stopping noradrenaline infusions.3 The effect of L-DOPA on the response to noradrenaline was prevented by the prior injection of the dopa decarboxylase inhibitor NSD 1024.4 The prior injection of the dopamine-beta-hydroxylase inhibitor diethyldithiocarbamate, only partially prevented the effect of L-DOPA on pressor responses to noradrenaline.5 The perfusion of noradrenaline (400 ng kg(-1) min(-1)) together with Krebs solution (10 ml/min) through an organ bath containing an isolated aortic strip, depressed the response of the strip to doses of noradrenaline after the infusion was stopped. Infusions of dopamine (0.5-8.0 mug kg(-1) min(-1)) had a similar effect. Fifteen minutes after adding L-DOPA (0.5 mg) to the bath and 10 min after washing it out, the response to noradrenaline was depressed in three out of four experiments.6 Infusions of noradrenaline (1 mug kg(-1) min(-1)) in an isolated heart perfused by Langendorf's method blocked the response to injected noradrenaline whilst perfusion was in progress. Infusions of dopamine (4-8 mug kg(-1) min(-1)) or of L-DOPA (200 mug kg(-1) min(-1)) did not have this effect.7 It is concluded that the effect of L-DOPA on pressor responses to noradrenaline in the pithed rat are mediated by its conversion to dopamine and noradrenaline.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4451761      PMCID: PMC1778065          DOI: 10.1111/j.1476-5381.1974.tb09664.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  14 in total

1.  Central hypotensive effect of L-3,4-dihydroxyphenylalanine in the rat.

Authors:  M Henning; A Rubenson
Journal:  J Pharm Pharmacol       Date:  1970-08       Impact factor: 3.765

2.  On the localization of the hypotensive effect of L-dopa.

Authors:  M Henning; A Rubenson; G Trolin
Journal:  J Pharm Pharmacol       Date:  1972-06       Impact factor: 3.765

3.  Effects of L-dopa in Parkinson's disease.

Authors:  R B Godwin-Austen; E B Tomlinson; C C Frears; H W Kok
Journal:  Lancet       Date:  1969-07-26       Impact factor: 79.321

4.  A method of stimulating different segments of the sympathetic and parasympathetic outflows from the spinal cord in the pithed rat.

Authors:  J S Gillespie; A MacLaren; D Pollock
Journal:  Br J Pharmacol       Date:  1969-10       Impact factor: 8.739

5.  The physiologic disposition and metabolism of norepinephrine in immunosympathectomized animals.

Authors:  L L Iversen; J Glowinski; J Axelrod
Journal:  J Pharmacol Exp Ther       Date:  1966-02       Impact factor: 4.030

6.  The origin of the decline in the vasopressor response to infused noradrenaline in the pithed rat.

Authors:  J S Gillespie; T C Muir
Journal:  Br J Pharmacol Chemother       Date:  1967-05

7.  The metabolism of orally administered L-Dopa in Parkinsonism.

Authors:  D B Calne; F Karoum; C R Ruthven; M Sandler
Journal:  Br J Pharmacol       Date:  1969-09       Impact factor: 8.739

8.  Modification of the cardiovascular effects of L-dopa by decarboxylase inhibitors.

Authors:  A M Watanabe; L C Parks; I J Kopin
Journal:  J Clin Invest       Date:  1971-06       Impact factor: 14.808

9.  Decrease of the 3,4-dihydroxyphenylalanine (DOPA) decarboxylase activities in human erythrocytes and mouse tissues after administration of DOPA.

Authors:  S S Tate; R Sweet; F H McDowell; A Meister
Journal:  Proc Natl Acad Sci U S A       Date:  1971-09       Impact factor: 11.205

10.  Hypotension caused by L-dopa.

Authors:  D B Calne; J Brennan; A S Spiers; G M Stern
Journal:  Br Med J       Date:  1970-02-21
View more
  3 in total

1.  Desensitization of the rat aortic strip to vasopressin by infusions of noradrenaline [proceedings].

Authors:  G J Abraham; P A Nasmyth
Journal:  Br J Pharmacol       Date:  1976-07       Impact factor: 8.739

2.  Selective inhibition of monoamine oxidase type B by MDL 72145 increases the central effects of L-dopa without modifying its cardiovascular effects.

Authors:  J R Fozard; M G Palfreyman; M Robin; M Zreika
Journal:  Br J Pharmacol       Date:  1986-01       Impact factor: 8.739

3.  Desensitization by noradrenaline of responses to stimulation of pre- and postsynaptic adrenoceptors.

Authors:  N Ball; J L Danks; S Dorudi; P A Nasmyth
Journal:  Br J Pharmacol       Date:  1982-05       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.